Standard-Dose Ursodeoxycholic Acid Improves Biochemical Liver Function and Fibrosis in Chronic Liver Disease: Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Authors:
- Young ChangYCYoung Chang
- Yong Kyun ChoYCYong Kyun Cho
- Young Seok KimYKYoung Seok Kim
- Sung-Eun KimSung-Eun Kim
- Gab Jin CheonGCGab Jin Cheon
- Ji Hoon KimJKJi Hoon Kim
- Hyun YangHYHyun Yang
- Won KimWKWon Kim
- Sang Bong AhnSASang Bong Ahn
- Eileen L. YoonEYEileen L. Yoon
- Jae Youn CheongJCJae Youn Cheong
- Jin-Woo LeeJLJin-Woo Lee
Open Access
- 1 January 2026
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (19) , e89
Abstract
Chang Y, et al. J Korean Med Sci. 2026 May;41:e89. https://doi.org/10.3346/jkms.2026.41.e89Keywords
Funding Information
- Daewoong Pharmaceutical Co., Ltd.
This publication has 36 references indexed in Scilit:
- Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver diseaseJournal of Hepatology, 2024
- Contemporary Epidemiology of Chronic Liver Disease and CirrhosisClinical Gastroenterology and Hepatology, 2020
- Cross-Cultural Validation of the Korean Version of the Chalder Fatigue ScaleInternational Journal of Behavioral Medicine, 2017
- miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver diseaseJournal of Hepatology, 2013
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisJournal of Hepatology, 2011
- High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitisHepatology, 2010
- Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology, 2006
- Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trialHepatology, 2004
- Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver diseaseClinics in Liver Disease, 2004
- Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patientsDigestive and Liver Disease, 2000